News


Gage Growth Corp. Announces DTC Eligibility and Closing of Sturgis Dispensary

December 3rd, 2021 - Ryan Allway

DETROIT, Dec. 3, 2021 /CNW/ – Gage Growth Corp. (“Gage” or the “Company”) (CSE: GAGE) (OTCQX: GAEGF), a leading high-quality cannabis premium brand and operator in Michigan, is pleased to announce that its subordinate voting shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and […]

cbdMD Therapeutics Announces Human Clinical Study In Collaboration With the University of South Carolina

December 3rd, 2021 - Ryan Allway

CHARLOTTE, N.C., December 03, 2021–(BUSINESS WIRE)–cbdMD, Inc. (NYSE American: YCBD, YCBDpA) (the “Company”), one of the leading, and most highly trusted and recognized cannabidiol (CBD) brands, announced today that it has commenced a preclinical human study with researchers at the University of South Carolina. The study will explore the effects of cbdMD’s proprietary broad spectrum […]

Schwazze Announces Transformational Capital Raise, Entry Into New Mexico & Provides Business Update

December 3rd, 2021 - Ryan Allway

Transformational $95 Million Private Financing for M&A Initiatives & Further Expansion Plans Signs Definitive Agreement to Acquire & Manage New Mexico Assets: Reynold Greenleaf & Associates, R. Greenleaf Organics, Medzen Services, Elemental Kitchen & Laboratories Schwazze Transitions to a Regional Operator with New Mexico Acquisitions   OTCQX: SHWZ DENVER, Dec. 3, 2021 /PRNewswire/ – Schwazze, (OTCQX:SHWZ) (“Schwazze” or the “Company”), one of the largest vertically integrated cannabis […]

Craft Cannabis is the Future & Micro-Cultivators Will Lead the Way

December 3rd, 2021 - Ryan Allway

  Canada’s legal cannabis industry is flooded with products that prioritize profits over quality. While many consumers are price-sensitive, Deloitte Canada found that 86% of Millennial and Gen Z consumers are willing to buy premium products. These trends mirror many other industries where premium products are beating out generic competitors. Maven Brands Inc. (CSE: MJ) […]

Sunstream IVXX Investment Corp. Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering

December 2nd, 2021 - Ryan Allway

CALGARY, AB, Dec. 2, 2021 /CNW/ – Sunstream IVXX Investment Corp. (“Sunstream IVXX”), an affiliate of SunStream Bancorp Inc., a joint venture sponsored by Sundial Growers Inc. (NASDAQ: SNDL), today announced that it has submitted a draft registration statement on a confidential basis to the U.S. Securities and Exchange Commission (the “SEC”) for a proposed initial public […]

Topical Cannabis Products from Ovation Science Lead Nevada Market

December 2nd, 2021 - Ryan Allway

Third Quarter Results Driven by 15% Increase in Royalty Revenue and Strong Fourth Quarter   VANCOUVER, BC and LAS VEGAS, Dec. 2, 2021 /PRNewswire/ – December 1st, 2021 (CSE: OVAT) (OTCQB: OVATF) – Ovation Science Inc. (“Ovation” or the “Company”), a topical and transdermal cannabis product development company with a patented skin delivery technology and backed by over twenty years of […]

Bespoke Extracts to Acquire Colorado Based Wonderleaf, LLC

December 2nd, 2021 - Ryan Allway

Transaction provides Bespoke with a licensed marijuana infused production facility in Colorado.   DENVER, Colorado., Dec. 02, 2021 (GLOBE NEWSWIRE) — Bespoke Extracts, Inc. (OTC: BSPK) (“Bespoke” or the “Company”), a company focusing on consumer products in CBD and regulated cannabis, today signed definitive documents to acquire the assets of Wonderleaf, LLC (“Wonderleaf”), a licensed […]

FSD Pharma Unveils Videos Demonstrating Positive Effects of Lucid-MS in Treating Multiple Sclerosis in Pre-Clinical Models (Mouse Models)

December 2nd, 2021 - Ryan Allway

TORONTO, December 02, 2021–(BUSINESS WIRE)–FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD Pharma” or the “Company“), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced today that it is sharing pre-clinical data, supported by an explanatory video, demonstrating the potentially disease-modifying effects of Lucid-MS, the Company’s […]

Launch of Tilray ’s Fast-Acting Oral Strips Highlights Commitment to Medical Cannabis Innovation and Patient Care

December 2nd, 2021 - Ryan Allway

2021-12-02 07:30 ET – News Release   NEW YORK and LEAMINGTON, Ontario, Dec. 02, 2021 (GLOBE NEWSWIRE) — Tilray, Inc. (“Tilray”) (NASDAQ | TSX: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced that its medical subsidiary, Aphria, has launched medical cannabis oral strips in THC and CBD-rich varieties. Powered by […]

Phase 1 Clinical Trial Data Indicate IGC’s THC-based Investigational New Drug May Reduce Symptoms of Dementia in Alzheimer’s Patients

December 2nd, 2021 - Ryan Allway

POTOMAC, Md., December 02, 2021–(BUSINESS WIRE)–(NYSE American: IGC), India Globalization Capital, Inc. (IGC) is excited to present preliminary positive secondary end point findings from its Phase 1 clinical trial for IGC-AD1. The investigational new drug, IGC-AD1, is IGC’s proprietary Tetrahydrocannabinol (THC)-based candidate designed to treat certain symptoms of Alzheimer’s disease. The results of the clinical […]

SOL Global Continues Principal Re-Payments Towards $50 Million Credit Facility

December 2nd, 2021 - Ryan Allway

TORONTO–(BUSINESS WIRE)–SOL Global Investments Corp. (the “Company” or “SOL Global”) (CSE: SOL) (OTCQ SOLCF) (Frankfurt: 9SB) is pleased to announce that it has repaid an additional $2.5 million toward its $50 million credit facility with an arm’s length lender (the “Credit Facility”), reducing the principal amount of the Credit Facility to $45 million. As disclosed in […]

Ayurcann Wins Two Leading Awards in Canada for Extraction Facility and Toll Processing Facility of the Year

December 2nd, 2021 - Ryan Allway

Toronto, Ontario, Dec. 02, 2021 (GLOBE NEWSWIRE) — Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: CDCLF, FSE:3ZQ0) (the “Company” or “Ayurcann”) a Canadian cannabis extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, is pleased to announce that it has won Extraction Facility of the Year and Toll Processing Facility […]

Flora Growth Continues International Expansion with Initial Exports to Mexico and Spain

December 2nd, 2021 - Ryan Allway

MIAMI & TORONTO–(BUSINESS WIRE)–Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, announced today that its Flora Beauty division has received initial orders for its Mind Naturals and Awe CBD skincare brands. These initial orders are for the Spanish and Mexican markets and […]

Oskare Capital and Sapphire Capital Partners LLP Launch First Ever UK SEIS/EIS Fund Targeting Medical & Pharma Cannabis Sector

December 1st, 2021 - Ryan Allway

LONDON–(BUSINESS WIRE)–Óskare Capital is proud to announce the launch of the first ever SEIS and EIS fund targeting the Medical and Pharmaceutical Cannabis sector. Óskare Capital UK will advise the Fund which is managed by Sapphire Capital Partners LLP.   The MEDCAN Fund is the first fund of its kind and will invest in both […]

Body and Mind Expands in Seaside California

December 1st, 2021 - Ryan Allway

Definitive agreements signed for acquisition of Seaside California Dispensary   LAS VEGAS and VANCOUVER, BC, Dec. 1, 2021 /CNW/ – Body and Mind Inc. (CSE: BAMM) (OTCQB: BMMJ) (the “Company” or “BaM”), a multi-state operator, is pleased to announce the entering into of two definitive agreements with Canopy Monterey Bay, LLC (“Canopy“) and the membership interest owners (the “Sellers“) of Canopy to […]

Bespoke Financial Raises $125 Million to Expand Lending Capacity, Fund the Growth of the Cannabis Industry

December 1st, 2021 - Ryan Allway

Additional capital will fuel rapid growth as demand for debt financing accelerates   LOS ANGELES, Dec. 01, 2021 (GLOBE NEWSWIRE) — Bespoke Financial, the nation’s first cannabis-focused fintech lending platform, announced today the closing of a $125 million credit facility.   This infusion of capital from institutional investment funds is a strong show of confidence in […]

Bespoke Financial Raises $125 Million to Expand Lending Capacity, Fund the Growth of the Cannabis Industry

December 1st, 2021 - Ryan Allway

Additional capital will fuel rapid growth as demand for debt financing accelerates   LOS ANGELES, Dec. 01, 2021 (GLOBE NEWSWIRE) — Bespoke Financial, the nation’s first cannabis-focused fintech lending platform, announced today the closing of a $125 million credit facility.   This infusion of capital from institutional investment funds is a strong show of confidence in […]

Cellular Goods launches inaugural products & ecommerce platform

December 1st, 2021 - Ryan Allway

LONDON, UK: Cellular Goods (LON: CBX), a UK-based provider of premium consumer products formulated with lab-made cannabinoids, has launched the inaugural product ranges and ecommerce platform, found at cellulargoods.co.   The launch comprises two product ranges and comes just nine months after the start-up of the Company’s commercial operations following its flotation on the London […]

Cannara Biotech Inc. upsizes CIBC Credit Facility to $22 Million

December 1st, 2021 - Ryan Allway

Refinancing will decrease the Company’s overall debt servicing costs to 4.3%   MONTREAL, Dec. 1, 2021 /CNW/ – Cannara Biotech Inc. (“Cannara” or the “Company“) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with two mega cultivation facilities based in Québec spanning over 1,650,000 sq. ft., today announced the refinancing […]

Humble & Fume Inc. Appoints New Chairman of the Board: Jakob Ripshtein, CEO of Perennial Brands Inc

November 30th, 2021 - Ryan Allway

Jakob Ripshtein is the former President of Aphria Inc. and Diageo Canada. Mr. Ripshtein brings a wealth of experience and knowledge of the cannabis and beverage alcohol market, including finance, sales and supply chain logistics.   TORONTO, Nov. 30, 2021 /PRNewswire/ – Humble & Fume Inc. (CSE: HMBL) (“Humble” or the “Company”), a leading North American distributor of cannabis and […]

Nextleaf Announces Glacial Gold to be Available from Coast to Coast

November 30th, 2021 - Ryan Allway

Vancouver, British Columbia–(Newsfile Corp. – November 30, 2021) – Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) (“Nextleaf“, “OILS“, or the “Company“), a federally regulated producer of cannabis oil that owns one of the largest portfolios of U.S. patents for the extraction and distillation of cannabinoids, is pleased to provide a commercial update on […]

Biomica Reports Positive Results from Pre-Clinical Studies in its Inflammatory Bowel Disease (IBD) Program

November 30th, 2021 - Ryan Allway

The results demonstrate the efficacy of Biomica’s live bacterial consortia, BMC333, for the treatment of IBD   REHOVOT, Israel, Nov. 30, 2021 /PRNewswire/ — Biomica, an emerging biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), reported today positive results from pre-clinical studies in its IBD program. In these studies, Biomica tested its […]

CannabCo Reveals 41% Odourless Cannabis™ Dry Flower Strain

November 30th, 2021 - Ryan Allway

CannabCo set to capture market with high THC Odourless Cannabis™ Products   BRAMPTON, ON, Nov. 30, 2021 /CNW/ – CannabCo Pharmaceutical Corp. (CannabCo), a Canadian company located in Brampton, Ontario, is pleased to announce a milestone achievement with the testing of one of the industry’s most potent cannabis strains at 41% total quantifiable cannabinoid content. […]

Red White & Bloom Provides Q3 2021 Financial Results: Revenue Increased $6 Million Over Q3 2020

November 30th, 2021 - Ryan Allway

Q3 year to date revenue increased 386% year over year to $36.9 million for the nine months ended September 30, 2021 EBITDA of $5.9 million is an increase of $11.7 million over Q3 2020, Adjusted sales1 of $99.2 million for the nine months ended September 30, 2021 Michigan Marijuana Regulatory Agency issued pre-qualification for RWB cannabis […]

Avicanna Enters into an Intellectual Property Licensing and Distribution Agreement with Established Pharmaceutical Company in Argentina

November 30th, 2021 - Ryan Allway

The partnership will focus on the licensing, supply, and expected commercialization of Avicanna’s cannabinoid-based drug candidate Trunerox™, in Argentina in the second half 2022   TORONTO, Nov. 30, 2021 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of […]

Rapid Dose Therapeutics Signs Agreement with AB Strategic Ventures for Business Development Advisory Services with First Nations Enterprises

November 30th, 2021 - Ryan Allway

BURLINGTON, Ontario–(BUSINESS WIRE)–Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, has entered into a strategic business development agreement with AB Strategic Ventures (“ABSV”) with the purpose of supporting relationship building with First Nations business enterprises through the fulfillment and sale of products made by […]

Delta 9 Opens US Based Showroom for Grow Pod and Equipment Sales

November 30th, 2021 - Ryan Allway

WINNIPEG, Manitoba, Nov. 30, 2021 (GLOBE NEWSWIRE) — DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: DLTNF) (“Delta 9” or the “Company”), is pleased to announce the opening of a US based showroom in Valley City, North Dakota, for sales of the Company’s proprietary grow system. The showroom facility will provide potential Grow Pod customers with […]

How to Capitalize on Germany’s Move to Legalize Cannabis

November 30th, 2021 - Ryan Allway

Germany’s incoming governing parties recently announced a formal agreement to legalize adult-use cannabis when they take power. While personal possession has already been decriminalized, the new proposal seeks to establish a regulated market for adult-use cannabis. The move could create an industry like those in Canada and some U.S. states. While the legislation won’t be […]

Next Green Wave Exceeds Projections, Releases Q3 2021 FS

November 30th, 2021 - Ryan Allway

Vancouver, British Columbia–(Newsfile Corp. – November 30, 2021) – Next Green Wave Holdings Inc. (CSE: NGW) (OTCQX: NXGWF) (“Next Green Wave”, “NGW” or the “Company”), a premium seed-to-shelf craft cannabis producer, is pleased to announce the following financial update: Release of Q3 2021 Results The Company has exceeded both its Q3 2021 Adjusted EBITDA* projection and Q3 […]

Revitalist Signs its 8th Clinic Lease in Bethesda, Maryland

November 30th, 2021 - Ryan Allway

VANCOUVER, British Columbia–(BUSINESS WIRE)–REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) is pleased to formally announce it has signed a lease for its 8th psychedelic assisted psychotherapy (“PAP”) clinic located at 4833 Rugby Avenue, Suite 600, Bethesda, Maryland, 20814. Located in the same state as prestigious Johns Hopkins University, […]


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading